SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

ARVNSell

ARVINAS, INC.

Andrew Saik · Chief Financial Officer

$46K−2.9%Jun 24
ARVNSell

Arvinas, Inc.

Andrew Saik · CFO

$111K−5.0%May 13
ARVNSell

Arvinas, Inc.

Angela M Cacace · Chief Scientific Officer

$96K−5.0%May 13
ARVNSell

Arvinas, Inc.

Noah Berkowitz · Chief Medical Officer

$110K−5.0%May 13
ARVNSell

ARVINAS, INC.

Randy Teel · President and CEO

$96K−3.3%May 13
ARVNSell

Arvinas, Inc.

Noah Berkowitz · Chief Medical Officer

$71K−3.0%Mar 19
ARVNSell

Arvinas, Inc.

John G Houston · Director

$466K−3.0%Mar 2
ARVNSell

Arvinas, Inc.

Angela M Cacace · Chief Scientific Officer

$44K−2.0%Feb 25
ARVNSell

Arvinas, Inc.

Andrew Saik · CFO

$61K−3.0%Feb 18
ARVNSell

Arvinas, Inc.

Angela M Cacace · Chief Scientific Officer

$55K−3.0%Feb 18
ARVNSell

Arvinas, Inc.

Noah Berkowitz · Chief Medical Officer

$68K−3.0%Feb 18
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$244KFeb 27
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$80K−1.0%Feb 27
ARVNSell

Arvinas, Inc.

Ronald Peck · Chief Medical Officer

$80K−2.0%Feb 27
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$80K−1.0%Feb 27
ARVNSell

Arvinas, Inc.

Ronald Peck · Chief Medical Officer

$32K−4.0%Aug 14
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$31K−1.0%Mar 3
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$174K−1.0%Mar 3
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$52K−1.0%Mar 3
ARVNSell

Arvinas, Inc.

Ronald Peck · Chief Medical Officer

$69K−13.0%Aug 16
ARVNSell

Arvinas, Inc.

Briggs Morrison · Director

$1.4M−51.0%Apr 18
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$1.1M−9.0%Mar 15
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$56K−1.0%Mar 4
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$102K−1.0%Mar 4
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$385K−1.0%Mar 4
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$1.5M−20.0%Feb 17
ARVNSell

Arvinas, Inc.

Briggs Morrison · Director

$1.4M−46.0%Jan 19
ARVNSell

Arvinas, Inc.

Ronald Peck · Chief Medical Officer

$1.6M−79.0%Jan 4
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$1.1M−9.0%Dec 21
ARVNSell

Arvinas, Inc.

Liam Ratcliffe · Director

$23.8M−66.0%Dec 16
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$1.7M−20.0%Nov 17
ARVNSell

Arvinas, Inc.

Liam Ratcliffe · Director

$11.5M−20.0%Nov 15
ARVNSell

Arvinas, Inc.

Liam Ratcliffe · Director

$16.0M−20.0%Nov 9
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$3.5M−5.0%Nov 3
ARVNSell

Arvinas, Inc.

Timothy M Shannon · Director

$2.2M−1.0%Sep 27
ARVNSell

Arvinas, Inc.

Timothy M Shannon · Director

$9.9M−5.0%Sep 27
ARVNSell

Arvinas, Inc.

Timothy M Shannon · Director

$16.4M−10.0%Sep 27
ARVNSell

Arvinas, Inc.

Timothy M Shannon · Director

$6.0M−4.0%Sep 27
ARVNSell

Arvinas, Inc.

Bradley Albert Margus · Director

$2.5M−33.0%Aug 27
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$1.7M−20.0%Aug 18
ARVNSell

Arvinas, Inc.

Ronald Peck · Chief Medical Officer

$123K−20.0%Aug 16
ARVNSell

Arvinas, Inc.

Bradley Albert Margus · Director

$975K−11.0%Aug 13
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$4.5M−5.0%Aug 4
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$1.7M−10.0%Jul 30
ARVNSell

Arvinas, Inc.

Ronald Peck · Chief Medical Officer

$1.5M−88.0%Jul 2
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$3.6M−5.0%Jun 11
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$1.7M−24.0%Apr 7
ARVNSell

Arvinas, Inc.

Ian Taylor · Chief Scientific Officer

$69K−1.0%Mar 2
ARVNSell

Arvinas, Inc.

Sean A Cassidy · CFO

$172K−1.0%Mar 2
ARVNSell

Arvinas, Inc.

John G Houston · President and CEO

$629KMar 2

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.